Flying schools to be rated by civil aviation regulator from October 2025
The DGCA outlined four key objectives for implementing this system:Standardisation of Training Quality: The rankings will offer a uniform method to compare institutions, helping to establish consistent training standards nationwide.Boosting Transparency and Accountability: The framework will allow students, regulators, and stakeholders to access reliable performance data, thereby reinforcing regulatory compliance and operational discipline among FTOs.Informed Choices for Aspiring Pilots: Student pilots will be able to assess FTOs based on quality indicators rather than location or cost, empowering them to make better educational choices.Support for Regulatory Oversight: The ranking data will assist authorities in recognising top-performing institutions for growth opportunities and identifying underperforming ones for increased supervision or intervention.DATA-DRIVEN EVALUATION AND MONITORINGUnder the new system, all FTOs will be required to submit performance metrics within designated timelines. The DGCA retains the right to conduct audits and on-ground inspections to verify submitted data. Any instance of misreporting or failure to comply with the framework may not only impact an institution's rank but could also lead to regulatory consequences.The aviation body asserts that this move will drive a culture of continuous improvement and excellence in pilot training. It also expects the initiative to contribute significantly to improved safety outcomes and the broader sustainability of the Indian aviation sector.In its statement, the DGCA concluded, 'The FTO Ranking System aims to safeguard student interests while also ensuring a steady stream of well-trained pilots, which is vital for the safe and sustainable growth of aviation in India.' - EndsMust Watch
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fibre2Fashion
31 minutes ago
- Fibre2Fashion
Global trade deterioration eases in Jun: S&P Global PMI data
Global trade conditions continued to deteriorate at the end of the second quarter (Q2) this year and the rate of decline eased for a second successive month and was only marginal, worldwide purchasing managers' index (PMI) surveys compiled by S&P Global Market Intelligence indicate. The seasonally-adjusted global PMI new export orders index, sponsored by JPMorgan, rose to 49.1 in June, up from 48 in May. Posting below the 50 neutral mark for a third successive month, the latest data indicated another contraction in trade activity. While the global manufacturing sector's export contraction persisted in June, the rate of decline softened to the slowest in the current three-month sequence, Jingyi Pan, economics associate director of operations-IMPG at S&P Global Market Intelligence, wrote on the company's website. Global trade conditions continued to deteriorate at the end Q2 2025 and the drop rate eased for a second month in a row and was only marginal, S&P Global Market Intelligence said. The number of top ten trading economies reporting higher goods exports was just two at the end of Q2: India and the US. India continued to lead export growth by a wide margin with a further acceleration in the growth rate. Further front-loading of goods orders ahead of the higher US tariffs deadline (July 9) supported the slower pace of deterioration in goods trade. This was evident with global production growth resuming at the quickest pace since February as manufacturers worked through existing orders in the lead up to the anticipated deadline. Additionally, stock building was again elevated among US manufacturers, though subdued across the rest of the world. Sentiment data also pointed to muted optimism regarding growth in the year ahead. Business confidence stayed below the series average reflecting some apprehension regarding the outlook, especially surrounding trade. Mentions of 'uncertainty' among goods producers were also elevated at multiples of the historical average, albeit down further from the peak in April. Even if trade uncertainty should ease in the coming months - the hangover from front-loading of goods orders in the first half of 2025 may lead to more subdued trade conditions in the coming months, Pan observed. The contraction in export business was broad-based in June, with the rates of reduction softening across both developed and emerging markets. After recording a steeper rate of export contraction for the first time in three years, emerging markets export business declined marginally at the end of the second quarter, he added. The number of top ten trading economies reporting higher goods exports remained at just two at the end of Q2 2025: India and the United States. India continued to lead export growth by a wide margin with a further acceleration in the rate of expansion. Demand strengthened from across the globe, especially from the United States. This led to Indian manufacturing exports rising at the third-fastest pace since data collection began for the series in March 2005. Goods export orders growth also accelerated in the United States to the quickest pace in just over a year despite trade policy impact. Modest slowdown in goods trade activity was recorded in Japan and South Korea, while only marginal declines were reported in the European Union and China. Fibre2Fashion News Desk (DS)
News18
an hour ago
- News18
'Pulp Fiction? Not Quite': How Indian Oranges Are Powering A French Medicine To Treat Varicose Veins
'We are proud that the oranges grown in Indian soil are now an integral part of a medicine used by millions across the world," Aurelien Breton, managing director, Servier India, told News18. 'We procure oranges from Maharashtra, Telangana, Andhra Pradesh, MP, and Rajasthan currently." According to IQVIA data, Daflon's 500mg and 1000mg stand at a value of Rs 61 crore as per moving annual turnover, May 2025, ranking 2nd in the varicose therapy market. The average number of patients treated in a month is 1.2 lakhs. The citrus supply chain The Indian-sourced oranges are first processed locally—cleaned, dried, and converted into powder form. This citrus powder is then exported to Servier's manufacturing headquarters in France, where it undergoes sophisticated processing to extract the active pharmaceutical ingredients (APIs). Interestingly, those APIs are then re-imported back to India, where the final formulation of Daflon is completed for domestic distribution. This circular, transcontinental journey of a single orange—from a farm in Nagpur to a lab in northern France and back to a pharmacy shelf in Delhi—highlights the globalisation of pharmaceutical supply chains and India's growing importance as a trusted sourcing and manufacturing hub. The move wasn't just about logistics or cost-efficiency. According to Breton, Indian oranges matched the quality standards required for flavonoid extraction. 'We achieved 100% reliance on local Indian oranges through our Indian supply chain with effect from the financial year 2021." Indian oranges matched the former Spanish and Mexican counterparts. '2000 metric tons of small oranges were procured in the financial year 2023-24. We work with aggregators and farmers in multiple states in India," said Breton. Company set to bring precision cancer medicine Servier Pharma is set to bring precision cancer treatments to India. 'Unlike traditional chemotherapy, these therapies act on specific genetic mutations that are responsible for causing the cancer," Breton said. Out of three novel drugs coming into the Indian market, the first drug, Ivosidenib, targets a mutated protein known as isocitrate dehydrogenase 1 (IDH1), which is found in a subset of patients with cholangiocarcinoma (a type of biliary tract cancer) and acute myeloid leukemia (a form of blood cancer). 'Epidemiological data show a high prevalence of biliary tract cancers along the Ganga River basin, supporting the need for this targeted option, which can significantly delay disease progression. In clinical trials, Ivosidenib has demonstrated more than a threefold improvement in survival for AML (blood cancer) patients." The drug was officially launched in India in June 2025.
Hans India
an hour ago
- Hans India
AP Chambers seeks a ban on export of raw human hair
Vijayawada: The Andhra Pradesh Chambers of Commerce and Industry Federation (AP Chambers) has submitted a detailed representation to Chief Minister Nara Chandrababu Naidu urging his personal intervention to stop the export of raw human hair, especially non-Remy (comb waste/GAoli/Chutti) hair, to safeguard the domestic human hair industry. In the representation, AP Chambers' president Potluri Bhaskara Rao and general secretary B Rajasekhar highlighted that in the last 20 years, the demand for Non-Remy Hair had gone up exponentially and Chinese buyers were buying huge quantities till 2012-13 from Indian exporters. But in the last 10 years, China has started reducing legal imports by smuggling Non-Remy (Comb Waste Hair) through Myanmar, Bangladesh, and Nepal where it is processed with child labour and again smuggled to China across border to avoid duties. Despite an earlier ban imposed in March 2022 by DGFT, exports resumed shortly after, including by previously blacklisted traders. Non-Remy Hair forms 85 percent of total exports and only 15 percent of hair is Remy Hair, sourced from temples, which is sold in auction/direct sales by temples. They pointed out that the Indian Human Hair Extension and Wig industry, currently valued at Rs 8,000 crore, has the potential to grow to Rs 30,000 crore in the next decade. The industry, which has a major presence in Madepalli and Eluru, provides employment to over 10 lakh women across rural India. AP Chambers also made key suggestions including the export of raw human hair having ITC (HS) Code 05010010 should be strictly prohibited to make it available for Indian hair processors for value-addition, Remy-type hair from temples should not be sold to China or Chinese agents, restrict temple hair auctions only to registered manufacturers/exporters and not to illegal trader to support 'Make it India' initiative of the Union government, establishment of a dedicated research chair for human hair at IIT Chennai to foster R & D, reduction of duties on human hair imported by countries wherever India has any bilateral agreements, incentives or subsidies to hair exported to African countries as they are the biggest consumers of hair and wigs as they will help boost the exports to African countries. Bhaskara Rao emphasised that this is a unique industry that transforms waste into valuable foreign exchange while empowering lakhs of women through rural employment. He requested the Chief Minister to take up the matter with the Union Minister of Commerce & Industry Piyush Goyal to ensure the long-term sustainability and growth of the human hair industry in Andhra Pradesh and India.
